ICD-11 Codes
for EA50.3 - Staphylococcal scarlatina

Teodor Jurukovski January 1, 1970

Fact checked by: Teodor Jurukovski

Use Code

Understanding Staphylococcal Scarlatina (ICD-11 Code EA50.3)

Staphylococcal scarlatina, identified by the ICD-11 code EA50.3, is a distinct dermatological condition characterized by a skin rash (exanthem) that is mediated by toxins produced by Staphylococcus aureus bacteria. This condition clinically resembles scarlet fever, which is typically caused by Streptococcus pyogenes. Staphylococcal scarlatina is often considered a milder manifestation compared to staphylococcal toxic shock syndrome, though it shares the common feature of being toxin-mediated.

Symptoms and Clinical Presentation of Staphylococcal Scarlatina

The primary presentation of Staphylococcal scarlatina is a characteristic rash that can appear red and feel like sandpaper. Patients typically experience fever and a general impairment of their condition. While it mimics scarlet fever, descriptions vary regarding specific mucosal findings; some reports note a strawberry tongue, while others explicitly state its absence, along with palatal petechiae. The exanthema usually progresses to desquamation, where the skin peels off in large flakes, but blistering is not a typical feature.

Causes and Risk Factors for Staphylococcal Scarlatina

The underlying cause of Staphylococcal scarlatina is the release of epidermolytic toxins by specific strains of Staphylococcus aureus. These toxins circulate in the bloodstream, leading to the characteristic skin manifestations. While the condition can affect individuals of any age, it is most frequently reported in children and young adults. General risk factors for staphylococcal infections, such as breaks in the skin or a weakened immune system, may predispose individuals to developing this condition.

Diagnosing Staphylococcal Scarlatina

The diagnosis of Staphylococcal scarlatina is primarily clinical, based on the characteristic scarlatiniform rash, fever, and the identification of Staphylococcus aureus as the source of the causative toxins. Medical professionals differentiate it from other staphylococcal infections, such as staphylococcal scalded skin syndrome (SSSS) and staphylococcal toxic shock syndrome (TSS), based on the specific clinical presentation and the absence of certain features like widespread blistering (in SSSS) or severe systemic complications like profound hypotension (in TSS).

Managing Staphylococcal Scarlatina: Treatment and Care

Treatment for Staphylococcal scarlatina focuses on addressing the underlying bacterial infection and managing the symptoms. This typically involves the administration of appropriate antibiotics to eliminate the Staphylococcus aureus bacteria. Supportive care is also crucial to manage fever and discomfort. Prompt medical attention is advised to prevent potential complications, although Staphylococcal scarlatina is generally considered less severe than other toxin-mediated staphylococcal diseases.

Synonyms and Related Terms for Staphylococcal Scarlatina

Staphylococcal scarlatina is also commonly referred to as Staphylococcal scarlet fever. It is important to distinguish it from streptococcal scarlet fever. While it shares some features with staphylococcal toxic shock syndrome (TSS), it is considered a distinct entity, often representing a milder form of toxin-mediated staphylococcal disease.

Coding and Documentation for Staphylococcal Scarlatina (EA50.3)

For accurate medical billing and record-keeping, the specific ICD-11 code EA50.3 should be used for Staphylococcal scarlatina. This code falls under the classification of toxin-mediated cutaneous reactions to distant or systemic bacterial infection. When documenting cases, healthcare providers should ensure the diagnosis is clearly stated to facilitate correct coding. The ICD-11 code for Staphylococcal scarlatina is EA50.3, which is essential for reporting and statistical purposes.